Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
salicylic acid ointment
- Development stage
- Unknown
- Lead developer
- Dr. Kulich Pharma
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Salicylic acid ointment is a topical keratolytic agent used to treat various skin conditions characterized by hyperkeratosis, such as psoriasis, ichthyosis, dandruff, corns, calluses, and warts. It works by increasing the amount of moisture in the skin and dissolving the substance that causes the skin cells to stick together, thereby facilitating the shedding of dead skin cells. Dr. Kulich Pharma manufactures and distributes this as a generic pharmaceutical product in various concentrations, such as 5% and 10%.
- Other names
- salicylic acid ointmentAcidi salicylici unguentum2-hydroxybenzoic acid ointment
Beyond the preview
Go deeper on salicylic acid ointment.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on salicylic acid ointment.